Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fluticasone propionate nasal spray is a synthetic glucocorticoid corticosteroid administered intranasally to treat symptoms of allergic and non-allergic rhinitis, including sneezing, runny or stuffy nose, itching, and watery eyes. It works by reducing inflammation in the nasal passages through inhibition of multiple types of inflammatory cells and mediators. The drug is also used for chronic rhinosinusitis and can be prescribed for both adults and children (with age restrictions depending on the brand). Fluticasone may slow growth in children with long-term use and carries risks such as increased intraocular pressure (glaucoma/cataracts), local irritation or ulceration in the nose, systemic steroid effects at high doses or prolonged use, and rare but serious allergic reactions[1][2][3][4][5][6][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fluticasone propionate nasal spray.